2 terminated. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Terminated 2 |
Follow tariquidar: new trials by email Literature Review of tariquidar trials Research Report on tariquidar
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Double-Blind, Randomized, Placebo-Controlled, Multicenter, Phase III Study of Tariquidar + Paclitaxel/Carboplatin as First-Line Therapy in Non-Small Cell Lung Cancer (NSCLC) Chemotherapy, tariquidar + paclitaxel/carboplatin, placebo + paclitaxel/carboplatin - Stage IIIb Non-small Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer | Phase 3 | Terminated | QLT Inc. | 540 | 2002-06-01 | 2012-05-23 |
| A Double-Blind, Randomized, Placebo-Controlled, Multicenter, Phase III Study of Tariquidar + Vinorelbine as First-Line Therapy in Non-Small Cell Lung Cancer (NSCLC) Chemotherapy, tariquidar + vinorelbine, placebo + vinorelbine - Stage IIIb Non-small Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer | Phase 3 | Terminated | QLT Inc. | 490 | 2002-06-01 | 2012-05-23 |
Carcinoma, Non-Small-Cell Lung (2)
QLT Inc. (2)